welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 390 blog entries.

Medicine Supply Notification: Bupropion (Zyban® ) 150mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bupropion (Zyban®) 150mg modified-release tablets. MSN/2022/100 Tier 3 – high impact Date of issue 1st December 2022 Bupropion (Zyban®) 150mg modified-release tablets will be out of stock until further notice. Various nicotine replacement therapies are available. NICE guidance highlights a range [...]

The post Medicine Supply Notification: Bupropion (Zyban® ) 150mg modified-release tablets appeared first on PSNC Website.

By |December 1st, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Bupropion (Zyban® ) 150mg modified-release tablets

Medicine Supply Notification: Acarbose 50mg and 100mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Acarbose 50mg and 100mg tablets. MSN/2022/099 Tier 2 – medium impact Date of issue 1st December 2022 Acarbose 50mg tablets are out of stock until w/c 5/12/2022 Acarbose 100mg tablets are out of stock until w/c 19/12/2022 Other medicines licensed for [...]

The post Medicine Supply Notification: Acarbose 50mg and 100mg tablets appeared first on PSNC Website.

By |December 1st, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Acarbose 50mg and 100mg tablets

Contractor Notice: Expiry of six HRT SSPs

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Oestrogel® Pump Pack (estradiol) 0.06% gel and Ovestin® (estriol 0.1%) 1mg cream is now available to meet normal demand. As a result the following  Serious Shortage Protocols, will expire at 23.59pm on Wednesday 30 November 2022. After this date, any prescriptions [...]

The post Contractor Notice: Expiry of six HRT SSPs appeared first on PSNC Website.

By |November 30th, 2022|Lexpos News|Comments Off on Contractor Notice: Expiry of six HRT SSPs

MHRA Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd)

Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd) Drug alert number: EL (22)A/49 Date issued: 29 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxycodone Hydrochloride 10mg/ml oral solution, PL 42176/0015 Batch Number Expiry Date Pack Size First [...]

The post MHRA Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd) appeared first on PSNC Website.

By |November 29th, 2022|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd)

Medicine Supply Notification: Atorvastatin (Lipitor® ) 20mg chewable tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Atorvastatin (Lipitor®) 20mg chewable tablets. MSN/2022/098 Tier 2 – medium impact Date of issue 24th November 2022 Atorvastatin (Lipitor®) 20mg chewable tablets are out of stock until late December 2022. Atorvastatin 20mg film-coated tablets and atorvastatin 20mg/5ml oral suspension remain available [...]

The post Medicine Supply Notification: Atorvastatin (Lipitor® ) 20mg chewable tablets appeared first on PSNC Website.

By |November 25th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Atorvastatin (Lipitor® ) 20mg chewable tablets